320 related articles for article (PubMed ID: 19117094)
1. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
Guglier S; Hricovíni M; Raman R; Polito L; Torri G; Casu B; Sasisekharan R; Guerrini M
Biochemistry; 2008 Dec; 47(52):13862-9. PubMed ID: 19117094
[TBL] [Abstract][Full Text] [Related]
2. Dynamic properties of biologically active synthetic heparin-like hexasaccharides.
Angulo J; Hricovíni M; Gairi M; Guerrini M; de Paz JL; Ojeda R; Martín-Lomas M; Nieto PM
Glycobiology; 2005 Oct; 15(10):1008-15. PubMed ID: 15958415
[TBL] [Abstract][Full Text] [Related]
3. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.
Guerrini M; Guglieri S; Beccati D; Torri G; Viskov C; Mourier P
Biochem J; 2006 Oct; 399(2):191-8. PubMed ID: 16796563
[TBL] [Abstract][Full Text] [Related]
4. Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.
Jemth P; Kreuger J; Kusche-Gullberg M; Sturiale L; Giménez-Gallego G; Lindahl U
J Biol Chem; 2002 Aug; 277(34):30567-73. PubMed ID: 12058038
[TBL] [Abstract][Full Text] [Related]
5. Interaction of heparins with fibroblast growth factors: conformational aspects.
Guerrini M; Hricovíni M; Torri G
Curr Pharm Des; 2007; 13(20):2045-56. PubMed ID: 17627538
[TBL] [Abstract][Full Text] [Related]
6. Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts.
Hricovíni M; Guerrini M; Bisio A
Eur J Biochem; 1999 May; 261(3):789-801. PubMed ID: 10215897
[TBL] [Abstract][Full Text] [Related]
7. Structural specificity of heparin binding in the fibroblast growth factor family of proteins.
Raman R; Venkataraman G; Ernst S; Sasisekharan V; Sasisekharan R
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2357-62. PubMed ID: 12604799
[TBL] [Abstract][Full Text] [Related]
8. Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1.
Guerrini M; Agulles T; Bisio A; Hricovini M; Lay L; Naggi A; Poletti L; Sturiale L; Torri G; Casu B
Biochem Biophys Res Commun; 2002 Mar; 292(1):222-30. PubMed ID: 11890696
[TBL] [Abstract][Full Text] [Related]
9. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M
J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling.
Jastrebova N; Vanwildemeersch M; Lindahl U; Spillmann D
J Biol Chem; 2010 Aug; 285(35):26842-26851. PubMed ID: 20576609
[TBL] [Abstract][Full Text] [Related]
11. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.
Jastrebova N; Vanwildemeersch M; Rapraeger AC; Giménez-Gallego G; Lindahl U; Spillmann D
J Biol Chem; 2006 Sep; 281(37):26884-92. PubMed ID: 16807244
[TBL] [Abstract][Full Text] [Related]
13. Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
Loo BM; Salmivirta M
J Biol Chem; 2002 Sep; 277(36):32616-23. PubMed ID: 12077148
[TBL] [Abstract][Full Text] [Related]
14. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
Casu B; Naggi A; Torri G
Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
[TBL] [Abstract][Full Text] [Related]
15. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
16. Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction.
Plum SM; Vu HA; Mercer B; Fogler WE; Fortier AH
Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):29-41. PubMed ID: 15106730
[TBL] [Abstract][Full Text] [Related]
17. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K
J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131
[TBL] [Abstract][Full Text] [Related]
18. Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions.
Naimy H; Buczek-Thomas JA; Nugent MA; Leymarie N; Zaia J
J Biol Chem; 2011 Jun; 286(22):19311-9. PubMed ID: 21471211
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
Razi N; Lindahl U
J Biol Chem; 1995 May; 270(19):11267-75. PubMed ID: 7744762
[TBL] [Abstract][Full Text] [Related]
20. Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage.
Myette JR; Soundararajan V; Behr J; Shriver Z; Raman R; Sasisekharan R
J Biol Chem; 2009 Dec; 284(50):35189-200. PubMed ID: 19726673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
